These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

671 related items for PubMed ID: 11979337

  • 1. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K, Osajima A, Hiroshige K, Watanabe H, Aibara K, Inada Y, Segawa K, Anai H, Takagi I, Ito A, Kamochi M, Kaizu K.
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [Abstract] [Full Text] [Related]

  • 2. The severity of hyperdynamic circulation may predict the effects of direct hemoperfusion with the adsorbent column using polymyxin B-immobilized fiber in patients with gram-negative septic shock.
    Uriu K, Osajima A, Kamochi M, Watanabe H, Aibara K, Kaizu K.
    Ther Apher; 2001 Feb; 5(1):25-30. PubMed ID: 11258606
    [Abstract] [Full Text] [Related]

  • 3. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity.
    Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, Endo S.
    Ther Apher Dial; 2006 Feb; 10(1):12-8. PubMed ID: 16556131
    [Abstract] [Full Text] [Related]

  • 4. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients.
    Sakamoto Y, Mashiko K, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y.
    ASAIO J; 2007 Feb; 53(3):324-8. PubMed ID: 17515723
    [Abstract] [Full Text] [Related]

  • 5. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock.
    Kumagai T, Takeyama N, Yabuki T, Harada M, Miki Y, Kanou H, Inoue S, Nakagawa T, Noguchi H.
    Shock; 2010 Nov; 34(5):461-6. PubMed ID: 20386499
    [Abstract] [Full Text] [Related]

  • 6. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock.
    Mitaka C, Tsuchida N, Kawada K, Nakajima Y, Imai T, Sasaki S.
    Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483
    [Abstract] [Full Text] [Related]

  • 7. Effect over time of endotoxin adsorption therapy in sepsis.
    Ueno T, Sugino M, Nemoto H, Shoji H, Kakita A, Watanabe M.
    Ther Apher Dial; 2005 Apr; 9(2):128-36. PubMed ID: 15828924
    [Abstract] [Full Text] [Related]

  • 8. Polymyxin B-immobilized fiber hemoperfusion attenuates increased plasma atrial natriuretic peptide and brain natriuretic Peptide levels in patients with septic shock.
    Nakamura T, Suzuki T, Kawagoe Y, Koide H.
    ASAIO J; 2008 Apr; 54(2):210-3. PubMed ID: 18356658
    [Abstract] [Full Text] [Related]

  • 9. Clinical Effects of a Longer Duration of Polymyxin B-Immobilized Fiber Column Direct Hemoperfusion Therapy for Severe Sepsis and Septic Shock.
    Yamashita C, Hara Y, Kuriyama N, Nakamura T, Nishida O.
    Ther Apher Dial; 2015 Aug; 19(4):316-23. PubMed ID: 26386218
    [Abstract] [Full Text] [Related]

  • 10. Changes in serum S100A12 and sRAGE associated with improvement of the PaO(2)/FiO(2) ratio following PMX-DHP therapy for postoperative septic shock.
    Takahashi G, Hoshikawa K, Matsumoto N, Shozushima T, Onodera C, Kan S, Akitomi S, Kikkawa T, Tomisawa Y, Kojika M, Sato N, Inoue Y, Suzuki K, Wakabayashi G, Endo S.
    Eur Surg Res; 2011 Aug; 47(3):135-40. PubMed ID: 21921634
    [Abstract] [Full Text] [Related]

  • 11. Polymyxin B hemoperfusion: a mechanistic perspective.
    Ronco C, Klein DJ.
    Crit Care; 2014 Jun 09; 18(3):309. PubMed ID: 25043934
    [Abstract] [Full Text] [Related]

  • 12. Polymyxin B-immobilized fiber hemoperfusion after emergency surgery in patients with chronic renal failure.
    Tojimbara T, Sato S, Nakajima I, Fuchinoue S, Akiba T, Teraoka S.
    Ther Apher Dial; 2004 Aug 09; 8(4):286-92. PubMed ID: 15274679
    [Abstract] [Full Text] [Related]

  • 13. Criteria for direct hemoperfusion with an immobilized polymyxin B fiber column based on oxygen metabolism.
    Kushi H, Miki T, Sakagami Y, Saito T, Tanjoh K.
    Ther Apher Dial; 2008 Aug 09; 12(4):292-7. PubMed ID: 18789116
    [Abstract] [Full Text] [Related]

  • 14. Polymyxin B-immobilized fiber column hemoperfusion therapy for septic shock.
    Mitaka C, Tomita M.
    Shock; 2011 Oct 09; 36(4):332-8. PubMed ID: 21654557
    [Abstract] [Full Text] [Related]

  • 15. Removal of 2-arachidonylglycerol by direct hemoperfusion therapy with polymyxin B immobilized fibers benefits patients with septic shock.
    Kase Y, Obata T, Okamoto Y, Iwai K, Saito K, Yokoyama K, Takinami M, Tanifuji Y.
    Ther Apher Dial; 2008 Oct 09; 12(5):374-80. PubMed ID: 18937720
    [Abstract] [Full Text] [Related]

  • 16. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
    Chihara S, Masuda Y, Tatsumi H, Nakano K, Shimada T, Murohashi T, Yamakage M.
    J Artif Organs; 2017 Mar 09; 20(1):71-75. PubMed ID: 27469940
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in septic shock patients treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
    Ebihara I, Hirayama K, Kaneko S, Nagai M, Ogawa Y, Fujita S, Usui J, Mase K, Yamagata K, Kobayashi M.
    Ther Apher Dial; 2008 Aug 09; 12(4):285-91. PubMed ID: 18789115
    [Abstract] [Full Text] [Related]

  • 18. [Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column].
    Kodama M, Tani T, Maekawa K, Hirasawa H, Otsuka T, Takahashi Y, Kaneko M.
    Nihon Geka Gakkai Zasshi; 1995 May 09; 96(5):277-85. PubMed ID: 7596338
    [Abstract] [Full Text] [Related]

  • 19. Effect of direct hemoperfusion using polymyxin B immobilized fiber on inflammatory mediators in patients with severe sepsis and septic shock.
    Kanesaka S, Sasaki J, Kuzume M, Narihara K, Takahashi Y.
    Int J Artif Organs; 2008 Oct 09; 31(10):891-7. PubMed ID: 19009507
    [Abstract] [Full Text] [Related]

  • 20. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber.
    Ono S, Tsujimoto H, Matsumoto A, Ikuta S, Kinoshita M, Mochizuki H.
    Am J Surg; 2004 Aug 09; 188(2):150-6. PubMed ID: 15249240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.